Analysis of the Novel Fanconi Anemia Gene SLX4/FANCP in Familial Breast Cancer Cases

Human Mutation

Volumn 34, Issue 1, 2013, Pages 70-73

  Bakker, Janine L ^a   van Mil, Saskia E ^a   Crossan, Gerry ^b   Sabbaghian, Nelly ^c,d   De Leeneer, Kim ^e   Poppe, Bruce ^e   Adank, Muriel ^a   Gille, Hans ^a   Verheul, Henk ^a   Meijers Heijboer, Hanne ^a   de Winter, Johan P ^a   Claes, Kathleen ^e   Tischkowitz, Marc ^c,d,f   Waisfisz, Quinten ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Familial breast cancer; Fanconi anemia; FANCP; Predisposition; SLX4

Indexed keywords

GENOMIC DNA; MITOMYCIN;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; EXON SKIPPING; FAMILIAL CANCER; FANCONI ANEMIA; FRAMESHIFT MUTATION; GENE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SLX4 GENE; SPLICING DEFECT; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FANCONI ANEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; RECOMBINASES; RNA SPLICE SITES;

EID: 84871608176     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22206     Document Type: Article

References (14)

1. Auerbach AD. 2009. Fanconi anemia and its diagnosis. Mutat Res 668:4-10.
2. Catucci I, Colombo M, Verderio P, Bernard L, Ficarazzi F, Mariette F, Barile M, Peissel B, Cattaneo E, Manoukian S, Radice P, Peterlongo P. 2012. Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases. PLoS One 7:e31038.
3. Fekairi S, Scaglione S, Chahwan C, Taylor ER, Tissier A, Coulon S, Dong MQ, Ruse C, Yates III JR, Russell P, Fuchs RP, McGowan CH. 2009. Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell 138:78-89.
4. Fernández-Rodríguez J, Quiles F, Blanco I, Teulé A, Feliubadaló L, Valle JD, Salinas M, Izquierdo A, Darder E, Schindler D, Capellá G, Brunet J, et al. 2012. Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families. BMC Cancer 12:84.
5. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, Okada H, Sarkissian T, Wong JA, Sakai T, De Stanchina E, Bristow RG, et al. 2002. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 22:6521-6532.
6. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A. 2011. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet 43:142-146.
7. Landwehr R, Bogdanova NV, Antonenkova N, Meyer A, Bremer M, Park-Simon TW, Hillemanns P, Karstens JH, Schindler D, Dörk T. 2011. Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer. Breast Cancer Res Treat 130:1021-1028.
8. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. 2010. Genetic susceptibility to breast cancer. Mol Oncol 4:174-191.
9. Moldovan GL, D'Andrea AD. 2009. How the Fanconi anemia pathway guards the genome. Annu Rev Genet 43:223-49.
10. Muñoz IM, Hain K, Déclais AC, Gardiner M, Toh GW, Sanchez-Pulido L, Heuckmann JM, Toth R, Macartney T, Eppink B, Kanaar R, Ponting CP, et al. 2009. Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell 35:116-127.
11. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. 2006. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 119:2417-2422.
12. Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, et al. 2011. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 43:138-141.
13. Tischkowitz M, Xia B. 2010. PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res 70:7353-7359.
14. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, Hughes D, Warren-Perry M, et al. 2010. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42:504-507.